Davide Moschese

3.5k total citations
40 papers, 448 citations indexed

About

Davide Moschese is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Davide Moschese has authored 40 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 18 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Davide Moschese's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (12 papers). Davide Moschese is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (12 papers). Davide Moschese collaborates with scholars based in Italy, Japan and United States. Davide Moschese's co-authors include Andrea Giacomelli, Spinello Antinori, Giuliano Rizzardini, Davide Mileto, Luigi Silvestri, Antonio Carbone, Antonio Luigi Pastore, Giovanni Palleschi, Vincenzo Petrozza and Maria Rita Gismondo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Urology.

In The Last Decade

Davide Moschese

35 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Moschese Italy	10	249	200	189	108	49	40	448
Thomas K. Wright Australia	7	106 0.4×	97 0.5×	52 0.3×	66 0.6×	92 1.9×	10	463
Khader Ghneim United States	8	74 0.3×	127 0.6×	108 0.6×	98 0.9×	17 0.3×	12	530
Santiago Pérez-Patrigeón Mexico	10	236 0.9×	70 0.3×	122 0.6×	120 1.1×	27 0.6×	25	434
M. Scott Killian United States	13	330 1.3×	123 0.6×	134 0.7×	169 1.6×	7 0.1×	27	776
Mohamed Elrefaei United States	13	202 0.8×	28 0.1×	130 0.7×	88 0.8×	16 0.3×	38	467
Seema Desai United States	11	260 1.0×	113 0.6×	236 1.2×	183 1.7×	8 0.2×	20	689
Tao Gui China	10	63 0.3×	119 0.6×	80 0.4×	87 0.8×	25 0.5×	21	372
Renée M. van der Sluis Netherlands	14	414 1.7×	135 0.7×	125 0.7×	220 2.0×	13 0.3×	27	668
Peter Ott Switzerland	11	234 0.9×	72 0.4×	76 0.4×	216 2.0×	40 0.8×	14	421
Thomas Norton United States	10	123 0.5×	64 0.3×	52 0.3×	90 0.8×	14 0.3×	19	319

Countries citing papers authored by Davide Moschese

Since Specialization

Citations

This map shows the geographic impact of Davide Moschese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Moschese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Moschese more than expected).

Fields of papers citing papers by Davide Moschese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Moschese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Moschese. The network helps show where Davide Moschese may publish in the future.

Co-authorship network of co-authors of Davide Moschese

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Moschese. A scholar is included among the top collaborators of Davide Moschese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Moschese. Davide Moschese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cossu, Maria Vittoria, Chiara Atzori, Francesco Petri, et al.. (2025). High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions. AIDS and Behavior. 29(10). 3315–3323.

Petri, Francesco, Alberto Rizzo, Andrea Cavallo, et al.. (2025). High Effectiveness of Ceftriaxone Monotherapy and Limited Value of Routine Test-of-Cure for Gonorrhea in a Low-Resistance Setting. Clinical Infectious Diseases. 81(6). e744–e745.

Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2024). Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition. AIDS and Behavior. 28(7). 2258–2263. 2 indexed citations

Ciccullo, Arturo, Gianmaria Baldin, Davide Moschese, et al.. (2024). Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort. Journal of Antimicrobial Chemotherapy. 80(1). 175–177. 2 indexed citations

Rizzo, Alberto, Davide Moschese, Andrea Giacomelli, et al.. (2024). Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections. Journal of Medical Virology. 96(8). e29852–e29852.

Rizzo, Alberto, Andrea Giacomelli, Davide Moschese, et al.. (2024). Detection and typization of HPV genotypes in subjects with oral and upper respiratory tract lesions, Milan, Italy. Infectious Diseases. 56(4). 293–298. 3 indexed citations

Rizzo, Alberto, Davide Moschese, Andrea Giacomelli, et al.. (2024). High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy. Journal of Medical Virology. 96(1). e29370–e29370. 5 indexed citations

Mancon, Alessandro, Angelo Roberto Raccagni, Gloria Gagliardi, et al.. (2024). Evaluation of analytical performance of the STANDARD ^TM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus. Emerging Microbes & Infections. 13(1). 2337666–2337666. 3 indexed citations

Rossotti, Roberto, Massimo Cernuschi, Federico D’Amico, et al.. (2023). Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis. Pathogens. 12(6). 798–798. 5 indexed citations

10.

Dragoni, Filippo, Barbara Rossetti, Francesca Lombardi, et al.. (2022). Dynamics of Total and Intact HIV-1 DNA in Virologically Suppressed Patients Switching to DTG-Based or ATV-Based Dual Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(4). 381–389. 2 indexed citations

11.

Borghetti, Alberto, Arturo Ciccullo, Davide Moschese, et al.. (2022). Are we ready for long‐acting? A feasibility evaluation of long‐acting cabotegravir–rilpivirine in clinical practice. Journal of Medical Virology. 94(10). 4970–4974. 3 indexed citations

12.

Lombardi, Francesca, Davide Moschese, Massimiliano Fabbiani, et al.. (2022). Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting. SHILAP Revista de lepidopterología. 23(1). 28–36. 3 indexed citations

13.

Moschese, Davide, Davide Mileto, Andrea Giacomelli, et al.. (2022). Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022. Eurosurveillance. 27(36). 39 indexed citations

14.

Ciccullo, Arturo, et al.. (2021). Evaluation of doravirine-based regimen population target in a large Italian clinical center. Antiviral Therapy. 26(3-5). 79–83. 1 indexed citations

15.

Tosato, Matteo, et al.. (2021). “Say Ninetynine”: It's Never Too Late to Recover from COVID-19. The Journal of Frailty & Aging. 10(1). 70–71. 1 indexed citations

16.

Baldin, Gianmaria, Arturo Ciccullo, Francesca Lombardi, et al.. (2020). Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice. AIDS Research and Human Retroviruses. 37(6). 429–432. 12 indexed citations

17.

Fabbiani, Massimiliano, Nicoletta Ciccarelli, Valeria Castelli, et al.. (2019). Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients. Journal of NeuroVirology. 25(6). 866–873. 7 indexed citations

18.

Borghetti, Alberto, Davide Moschese, Antonella Cingolani, et al.. (2019). Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV‐1 with suppressed HIV RNA: derivation of a predictive score for virological failure. HIV Medicine. 20(9). 624–627. 4 indexed citations

19.

Ciccullo, Arturo, A D’Avino, Gianmaria Baldin, et al.. (2018). Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice.. PubMed. 26(4). 336–340. 10 indexed citations

20.

Ciccullo, Arturo, Roberta Gagliardini, Gianmaria Baldin, et al.. (2018). An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy. HIV Medicine. 19(6). 369–375. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact